Puma Biotechnology reported 13.93 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amgen 18.6 0.53 Sep/2026
Biogen 29.15 5.92 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Daiichi Sankyo 18.6 1.54 Sep/2026
Exelixis 18.43 0.41 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
Glaxosmithkline 15.17 0.08 Sep/2026
Incyte 54.54 40.08 Sep/2026
Moderna 27.22 14.51 Jun/2023
Novartis 19.17 3.24 Sep/2026
Pfizer 15.2 3.72 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
Takeda 21.04 3.36 Sep/2026
TG Therapeutics 75.56 55.92 Sep/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 29.35 1.3 Sep/2026